Yuet-Kin Leung
Concepts (458)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Estrogen Receptor beta | 17 | 2019 | 54 | 3.420 |
Why?
| Endocrine Disruptors | 7 | 2025 | 32 | 2.700 |
Why?
| Prostatic Neoplasms | 15 | 2022 | 398 | 2.570 |
Why?
| Phenols | 10 | 2025 | 92 | 2.030 |
Why?
| Epigenesis, Genetic | 11 | 2025 | 406 | 2.010 |
Why?
| Benzhydryl Compounds | 9 | 2021 | 68 | 1.990 |
Why?
| Environmental Pollutants | 4 | 2024 | 106 | 1.560 |
Why?
| DNA Methylation | 13 | 2025 | 592 | 1.320 |
Why?
| Estrogens | 7 | 2020 | 223 | 1.210 |
Why?
| Gene Expression Regulation, Neoplastic | 9 | 2024 | 857 | 1.210 |
Why?
| Cell Line, Tumor | 21 | 2024 | 1470 | 1.000 |
Why?
| Signal Transduction | 12 | 2021 | 1671 | 0.960 |
Why?
| Estradiol | 9 | 2021 | 214 | 0.960 |
Why?
| Carcinoma, Hepatocellular | 2 | 2024 | 202 | 0.900 |
Why?
| Breast Neoplasms | 7 | 2016 | 1212 | 0.870 |
Why?
| beta Catenin | 1 | 2024 | 102 | 0.850 |
Why?
| Cell Movement | 4 | 2020 | 268 | 0.850 |
Why?
| Wnt Signaling Pathway | 1 | 2024 | 94 | 0.840 |
Why?
| Endocrine System | 1 | 2023 | 16 | 0.840 |
Why?
| Receptors, Androgen | 2 | 2022 | 46 | 0.810 |
Why?
| Liver Neoplasms | 2 | 2024 | 333 | 0.790 |
Why?
| Occupational Exposure | 3 | 2021 | 111 | 0.770 |
Why?
| Mice, Knockout | 2 | 2024 | 879 | 0.760 |
Why?
| Antineoplastic Agents | 5 | 2021 | 1222 | 0.750 |
Why?
| Cell Proliferation | 10 | 2022 | 1023 | 0.740 |
Why?
| Environmental Exposure | 7 | 2024 | 216 | 0.710 |
Why?
| Protein Kinase Inhibitors | 5 | 2023 | 227 | 0.700 |
Why?
| Toxicity Tests | 1 | 2020 | 57 | 0.690 |
Why?
| Humans | 64 | 2025 | 52483 | 0.650 |
Why?
| Mammary Neoplasms, Experimental | 2 | 2017 | 122 | 0.620 |
Why?
| Animals | 26 | 2024 | 13505 | 0.600 |
Why?
| Chromosomes, Human, X | 1 | 2018 | 18 | 0.590 |
Why?
| Leukemia, Myeloid, Acute | 3 | 2023 | 203 | 0.530 |
Why?
| Protective Clothing | 1 | 2015 | 6 | 0.500 |
Why?
| Firefighters | 1 | 2015 | 3 | 0.500 |
Why?
| Estrogen Antagonists | 1 | 2015 | 21 | 0.500 |
Why?
| Antineoplastic Agents, Hormonal | 2 | 2014 | 53 | 0.490 |
Why?
| Transcriptional Activation | 4 | 2013 | 122 | 0.470 |
Why?
| Response Elements | 2 | 2013 | 29 | 0.460 |
Why?
| MicroRNAs | 3 | 2016 | 387 | 0.440 |
Why?
| CpG Islands | 8 | 2025 | 121 | 0.440 |
Why?
| Prostate | 6 | 2016 | 116 | 0.440 |
Why?
| Female | 34 | 2025 | 28171 | 0.430 |
Why?
| Fetal Blood | 3 | 2025 | 80 | 0.430 |
Why?
| Promoter Regions, Genetic | 4 | 2019 | 467 | 0.420 |
Why?
| Sp1 Transcription Factor | 2 | 2024 | 20 | 0.420 |
Why?
| Prenatal Exposure Delayed Effects | 4 | 2021 | 197 | 0.410 |
Why?
| Exons | 1 | 2013 | 102 | 0.410 |
Why?
| Apoptosis | 4 | 2022 | 1119 | 0.410 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 129 | 0.400 |
Why?
| Male | 34 | 2024 | 26761 | 0.400 |
Why?
| Rats | 11 | 2021 | 3220 | 0.400 |
Why?
| Diet, High-Fat | 4 | 2021 | 236 | 0.370 |
Why?
| Proto-Oncogene Proteins c-ret | 2 | 2022 | 33 | 0.350 |
Why?
| Maternal Exposure | 3 | 2025 | 103 | 0.350 |
Why?
| Muscle Proteins | 1 | 2013 | 321 | 0.350 |
Why?
| Placenta | 2 | 2025 | 153 | 0.340 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2019 | 221 | 0.340 |
Why?
| Receptors, Estrogen | 4 | 2019 | 131 | 0.330 |
Why?
| Pregnancy | 11 | 2025 | 2680 | 0.330 |
Why?
| Pyrimidines | 2 | 2022 | 199 | 0.330 |
Why?
| Adenocarcinoma | 2 | 2011 | 405 | 0.320 |
Why?
| Spermatogenesis | 2 | 2021 | 13 | 0.320 |
Why?
| RNA, Messenger | 5 | 2022 | 1132 | 0.310 |
Why?
| HEK293 Cells | 5 | 2021 | 229 | 0.310 |
Why?
| Air Pollutants, Occupational | 2 | 2020 | 14 | 0.300 |
Why?
| Orphan Nuclear Receptors | 2 | 2019 | 14 | 0.300 |
Why?
| Dose-Response Relationship, Drug | 6 | 2021 | 1378 | 0.300 |
Why?
| fms-Like Tyrosine Kinase 3 | 3 | 2023 | 20 | 0.290 |
Why?
| Transcription, Genetic | 4 | 2013 | 378 | 0.290 |
Why?
| Epigenomics | 2 | 2019 | 75 | 0.280 |
Why?
| Mass Spectrometry | 2 | 2024 | 292 | 0.280 |
Why?
| Protein Isoforms | 4 | 2013 | 123 | 0.270 |
Why?
| Mutation | 5 | 2023 | 1347 | 0.270 |
Why?
| Metabolome | 2 | 2025 | 101 | 0.270 |
Why?
| Mice | 6 | 2024 | 5949 | 0.260 |
Why?
| Phosphorylation | 5 | 2021 | 528 | 0.250 |
Why?
| Gene Expression Profiling | 5 | 2015 | 1105 | 0.250 |
Why?
| Cytochrome P-450 CYP1A1 | 1 | 2005 | 26 | 0.240 |
Why?
| Androgens | 2 | 2022 | 70 | 0.240 |
Why?
| Lung Neoplasms | 3 | 2022 | 636 | 0.240 |
Why?
| Protein Processing, Post-Translational | 3 | 2012 | 153 | 0.230 |
Why?
| Chironomidae | 1 | 2004 | 1 | 0.230 |
Why?
| Ferrochelatase | 1 | 2004 | 1 | 0.230 |
Why?
| Veterans | 2 | 2021 | 583 | 0.230 |
Why?
| Aqueous Humor | 1 | 2024 | 10 | 0.230 |
Why?
| Retinal Artery Occlusion | 1 | 2024 | 13 | 0.230 |
Why?
| NF-kappa B | 1 | 2006 | 322 | 0.220 |
Why?
| Structure-Activity Relationship | 5 | 2022 | 404 | 0.220 |
Why?
| Butter | 2 | 2021 | 4 | 0.220 |
Why?
| Copper | 1 | 2004 | 47 | 0.220 |
Why?
| Proteome | 1 | 2006 | 171 | 0.220 |
Why?
| Nanoparticles | 2 | 2016 | 160 | 0.220 |
Why?
| Glycyrrhiza | 1 | 2003 | 4 | 0.220 |
Why?
| Pyridines | 2 | 2023 | 132 | 0.220 |
Why?
| Drug Discovery | 2 | 2021 | 93 | 0.220 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2003 | 60 | 0.210 |
Why?
| Proteins | 2 | 2006 | 348 | 0.210 |
Why?
| Wounds and Injuries | 2 | 2018 | 309 | 0.210 |
Why?
| Disease Models, Animal | 3 | 2024 | 1478 | 0.210 |
Why?
| Binding Sites | 2 | 2022 | 377 | 0.210 |
Why?
| Hormones | 1 | 2023 | 59 | 0.210 |
Why?
| Antineoplastic Agents, Phytogenic | 3 | 2016 | 71 | 0.200 |
Why?
| Tumor Suppressor Proteins | 2 | 2020 | 130 | 0.200 |
Why?
| Methylcholanthrene | 1 | 2002 | 10 | 0.190 |
Why?
| Neoplasm Invasiveness | 2 | 2014 | 278 | 0.190 |
Why?
| Sp3 Transcription Factor | 1 | 2022 | 5 | 0.190 |
Why?
| RNA Polymerase II | 1 | 2022 | 14 | 0.190 |
Why?
| Infertility, Male | 1 | 2021 | 11 | 0.190 |
Why?
| Aminoquinolines | 1 | 2021 | 8 | 0.190 |
Why?
| Proteomics | 1 | 2024 | 329 | 0.180 |
Why?
| Phthalazines | 1 | 2021 | 20 | 0.180 |
Why?
| Thiophenes | 1 | 2021 | 38 | 0.180 |
Why?
| Disease Susceptibility | 2 | 2012 | 95 | 0.180 |
Why?
| Forkhead Transcription Factors | 2 | 2012 | 116 | 0.180 |
Why?
| Plant Extracts | 1 | 2003 | 194 | 0.180 |
Why?
| Computational Biology | 3 | 2019 | 212 | 0.180 |
Why?
| Glucuronosyltransferase | 1 | 2002 | 122 | 0.180 |
Why?
| Risk | 3 | 2017 | 316 | 0.180 |
Why?
| Dietary Fats | 1 | 2021 | 130 | 0.180 |
Why?
| Ovarian Neoplasms | 1 | 2005 | 459 | 0.180 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 134 | 0.170 |
Why?
| Adult | 11 | 2025 | 14161 | 0.170 |
Why?
| Infant, Newborn | 4 | 2025 | 2867 | 0.170 |
Why?
| Transforming Growth Factor beta | 1 | 2021 | 138 | 0.170 |
Why?
| DNA Modification Methylases | 1 | 2020 | 28 | 0.170 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 41 | 0.170 |
Why?
| Estrogen Receptor alpha | 3 | 2019 | 85 | 0.170 |
Why?
| Isocitrate Dehydrogenase | 1 | 2020 | 20 | 0.170 |
Why?
| DNA Repair Enzymes | 1 | 2020 | 43 | 0.170 |
Why?
| Pyruvate Kinase | 1 | 2020 | 7 | 0.170 |
Why?
| Molecular Sequence Data | 4 | 2006 | 778 | 0.170 |
Why?
| Pyrroles | 1 | 2020 | 71 | 0.170 |
Why?
| Hair | 2 | 2018 | 29 | 0.170 |
Why?
| Drug Design | 1 | 2020 | 120 | 0.160 |
Why?
| Up-Regulation | 3 | 2019 | 454 | 0.160 |
Why?
| Sequence Analysis, RNA | 1 | 2020 | 100 | 0.160 |
Why?
| Random Allocation | 2 | 2017 | 285 | 0.160 |
Why?
| Pharyngeal Neoplasms | 1 | 2019 | 2 | 0.160 |
Why?
| Endometrial Neoplasms | 1 | 2020 | 144 | 0.160 |
Why?
| Glioma | 1 | 2020 | 78 | 0.160 |
Why?
| Mouth Neoplasms | 1 | 2019 | 22 | 0.160 |
Why?
| Collagen Type III | 1 | 2019 | 7 | 0.160 |
Why?
| Subcellular Fractions | 2 | 2012 | 34 | 0.160 |
Why?
| Cost of Illness | 2 | 2018 | 121 | 0.160 |
Why?
| Amino Acid Sequence | 3 | 2006 | 578 | 0.150 |
Why?
| Liver Failure, Acute | 1 | 2019 | 56 | 0.150 |
Why?
| Tissue Array Analysis | 3 | 2016 | 46 | 0.150 |
Why?
| Military Personnel | 1 | 2020 | 177 | 0.150 |
Why?
| Stress, Psychological | 1 | 2020 | 273 | 0.150 |
Why?
| Methylmercury Compounds | 1 | 2018 | 5 | 0.150 |
Why?
| Collagen Type I | 1 | 2019 | 83 | 0.150 |
Why?
| Denmark | 1 | 2018 | 23 | 0.150 |
Why?
| Mortality, Premature | 1 | 2018 | 12 | 0.150 |
Why?
| Polychlorinated Biphenyls | 1 | 2018 | 35 | 0.140 |
Why?
| Depressive Disorder | 1 | 2020 | 334 | 0.140 |
Why?
| Pregnancy in Diabetics | 1 | 2018 | 27 | 0.140 |
Why?
| Anxiety | 1 | 2020 | 300 | 0.140 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 28 | 0.140 |
Why?
| Water Pollutants, Chemical | 1 | 2018 | 54 | 0.140 |
Why?
| Urethane | 1 | 2017 | 5 | 0.140 |
Why?
| Histone Demethylases | 1 | 2017 | 19 | 0.140 |
Why?
| Pneumonia, Viral | 1 | 2020 | 178 | 0.140 |
Why?
| Morbidity | 1 | 2018 | 145 | 0.140 |
Why?
| Neoplasms | 2 | 2005 | 1325 | 0.140 |
Why?
| Cells, Cultured | 4 | 2019 | 1567 | 0.140 |
Why?
| Coronavirus Infections | 1 | 2020 | 188 | 0.140 |
Why?
| Protein Binding | 2 | 2011 | 667 | 0.140 |
Why?
| Mammary Glands, Animal | 1 | 2017 | 69 | 0.130 |
Why?
| Research Design | 1 | 2019 | 359 | 0.130 |
Why?
| Gene Expression | 2 | 2018 | 618 | 0.130 |
Why?
| Rats, Sprague-Dawley | 5 | 2021 | 1563 | 0.130 |
Why?
| Fibroblasts | 1 | 2019 | 355 | 0.130 |
Why?
| Sex Characteristics | 1 | 2018 | 198 | 0.130 |
Why?
| Cholesterol | 1 | 2017 | 153 | 0.130 |
Why?
| Immunohistochemistry | 4 | 2016 | 979 | 0.130 |
Why?
| 5-Methylcytosine | 1 | 2016 | 16 | 0.130 |
Why?
| Brain Neoplasms | 1 | 2020 | 291 | 0.130 |
Why?
| Heart Diseases | 1 | 2019 | 216 | 0.130 |
Why?
| Paclitaxel | 1 | 2016 | 89 | 0.130 |
Why?
| Environmental Health | 1 | 2016 | 14 | 0.130 |
Why?
| Membrane Proteins | 2 | 2010 | 335 | 0.130 |
Why?
| Myocardium | 1 | 2019 | 453 | 0.130 |
Why?
| Carcinoma, Squamous Cell | 1 | 2019 | 332 | 0.130 |
Why?
| Developed Countries | 1 | 2016 | 17 | 0.130 |
Why?
| Reproduction | 1 | 2016 | 64 | 0.130 |
Why?
| Sexual Maturation | 1 | 2015 | 19 | 0.130 |
Why?
| Embryo Implantation | 1 | 2015 | 5 | 0.120 |
Why?
| Risk Factors | 5 | 2020 | 3889 | 0.120 |
Why?
| Pandemics | 1 | 2020 | 585 | 0.120 |
Why?
| Embryonic Development | 1 | 2015 | 18 | 0.120 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2016 | 107 | 0.120 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2016 | 56 | 0.120 |
Why?
| Developing Countries | 1 | 2016 | 63 | 0.120 |
Why?
| Interferons | 1 | 2015 | 40 | 0.120 |
Why?
| Myeloid Cells | 1 | 2015 | 39 | 0.120 |
Why?
| RNA, Untranslated | 1 | 2015 | 14 | 0.120 |
Why?
| Histone Code | 1 | 2015 | 32 | 0.120 |
Why?
| Prostatectomy | 1 | 2016 | 84 | 0.120 |
Why?
| Polyglycolic Acid | 1 | 2015 | 7 | 0.120 |
Why?
| Histidine | 1 | 2015 | 15 | 0.120 |
Why?
| Chemistry, Pharmaceutical | 1 | 2015 | 35 | 0.120 |
Why?
| Tumor Cells, Cultured | 3 | 2022 | 460 | 0.120 |
Why?
| Particle Size | 1 | 2015 | 82 | 0.120 |
Why?
| Middle Aged | 8 | 2024 | 13028 | 0.120 |
Why?
| Receptor, erbB-2 | 1 | 2015 | 80 | 0.120 |
Why?
| Drug Carriers | 1 | 2015 | 73 | 0.120 |
Why?
| Aged | 7 | 2024 | 10121 | 0.120 |
Why?
| Image Processing, Computer-Assisted | 1 | 2016 | 253 | 0.110 |
Why?
| Polyethylene Glycols | 1 | 2015 | 90 | 0.110 |
Why?
| Lysosomes | 1 | 2015 | 76 | 0.110 |
Why?
| Inflammasomes | 1 | 2015 | 66 | 0.110 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2014 | 48 | 0.110 |
Why?
| Lactic Acid | 1 | 2015 | 78 | 0.110 |
Why?
| HMGA Proteins | 1 | 2014 | 2 | 0.110 |
Why?
| Base Sequence | 3 | 2005 | 640 | 0.110 |
Why?
| Maternal Mortality | 1 | 2014 | 30 | 0.110 |
Why?
| Isoenzymes | 2 | 2005 | 166 | 0.110 |
Why?
| Caspase 7 | 1 | 2013 | 7 | 0.110 |
Why?
| Malaria | 1 | 2014 | 42 | 0.110 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 483 | 0.110 |
Why?
| MCF-7 Cells | 1 | 2013 | 64 | 0.110 |
Why?
| Histones | 2 | 2015 | 314 | 0.110 |
Why?
| Repressor Proteins | 1 | 2014 | 155 | 0.110 |
Why?
| 5' Untranslated Regions | 1 | 2013 | 30 | 0.110 |
Why?
| Histone Acetyltransferases | 1 | 2013 | 24 | 0.110 |
Why?
| Open Reading Frames | 1 | 2013 | 55 | 0.100 |
Why?
| Tuberculosis | 1 | 2014 | 152 | 0.100 |
Why?
| Drug Delivery Systems | 1 | 2015 | 154 | 0.100 |
Why?
| HIV Infections | 2 | 2014 | 389 | 0.100 |
Why?
| DNA | 1 | 2016 | 549 | 0.100 |
Why?
| Estrogens, Non-Steroidal | 2 | 2015 | 15 | 0.100 |
Why?
| Vehicle Emissions | 1 | 2012 | 10 | 0.100 |
Why?
| Metabolomics | 2 | 2025 | 150 | 0.100 |
Why?
| Models, Biological | 2 | 2017 | 735 | 0.100 |
Why?
| Transcriptome | 1 | 2015 | 370 | 0.100 |
Why?
| Genetic Predisposition to Disease | 1 | 2015 | 528 | 0.100 |
Why?
| Doxorubicin | 1 | 2013 | 241 | 0.090 |
Why?
| Air Pollutants | 1 | 2012 | 75 | 0.090 |
Why?
| RNA Splicing | 1 | 2012 | 41 | 0.090 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 82 | 0.090 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 509 | 0.090 |
Why?
| Cisplatin | 1 | 2013 | 285 | 0.090 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 94 | 0.090 |
Why?
| Antibodies | 1 | 2012 | 159 | 0.090 |
Why?
| MAP Kinase Signaling System | 1 | 2012 | 121 | 0.090 |
Why?
| Diet | 1 | 2015 | 587 | 0.090 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 582 | 0.090 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2011 | 36 | 0.090 |
Why?
| Protein Biosynthesis | 1 | 2013 | 258 | 0.090 |
Why?
| Racemases and Epimerases | 1 | 2011 | 18 | 0.090 |
Why?
| Cell Cycle | 1 | 2012 | 230 | 0.090 |
Why?
| Cell Transformation, Neoplastic | 2 | 2017 | 184 | 0.090 |
Why?
| Models, Genetic | 1 | 2011 | 169 | 0.090 |
Why?
| Cell Nucleus | 2 | 2016 | 187 | 0.090 |
Why?
| Molecular Structure | 2 | 2021 | 314 | 0.090 |
Why?
| Introns | 1 | 2010 | 53 | 0.080 |
Why?
| Gene Expression Regulation | 3 | 2015 | 990 | 0.080 |
Why?
| Testosterone | 2 | 2016 | 141 | 0.080 |
Why?
| Carcinogens | 2 | 2015 | 193 | 0.080 |
Why?
| Gene Silencing | 1 | 2010 | 118 | 0.080 |
Why?
| Manganese Poisoning | 1 | 2009 | 5 | 0.080 |
Why?
| Disease-Free Survival | 1 | 2010 | 460 | 0.080 |
Why?
| Young Adult | 4 | 2025 | 4329 | 0.080 |
Why?
| Proportional Hazards Models | 1 | 2010 | 443 | 0.080 |
Why?
| Oligonucleotide Array Sequence Analysis | 3 | 2007 | 405 | 0.080 |
Why?
| Asthma | 1 | 2012 | 316 | 0.070 |
Why?
| Methylation | 2 | 2020 | 126 | 0.070 |
Why?
| Community-Based Participatory Research | 1 | 2009 | 203 | 0.070 |
Why?
| Enzyme Activation | 2 | 2006 | 270 | 0.070 |
Why?
| Sequence Analysis, DNA | 2 | 2019 | 229 | 0.070 |
Why?
| Quality-Adjusted Life Years | 2 | 2018 | 66 | 0.070 |
Why?
| Apigenin | 1 | 2006 | 7 | 0.070 |
Why?
| Estrogen Receptor Modulators | 1 | 2006 | 5 | 0.070 |
Why?
| Presenilin-2 | 1 | 2006 | 2 | 0.070 |
Why?
| Yeasts | 1 | 2006 | 9 | 0.070 |
Why?
| Sequence Analysis, Protein | 1 | 2006 | 19 | 0.070 |
Why?
| Dimerization | 1 | 2006 | 51 | 0.070 |
Why?
| Growth Differentiation Factor 1 | 1 | 2006 | 2 | 0.060 |
Why?
| Interleukin-12 | 1 | 2006 | 27 | 0.060 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 52 | 0.060 |
Why?
| Sex Factors | 2 | 2019 | 727 | 0.060 |
Why?
| Interleukin-8 | 1 | 2006 | 86 | 0.060 |
Why?
| Mortality | 2 | 2018 | 105 | 0.060 |
Why?
| Cohort Studies | 1 | 2010 | 1542 | 0.060 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 105 | 0.060 |
Why?
| Benzo(a)pyrene | 1 | 2005 | 13 | 0.060 |
Why?
| Epithelium | 1 | 2005 | 65 | 0.060 |
Why?
| Models, Molecular | 1 | 2006 | 348 | 0.060 |
Why?
| Phthalic Acids | 1 | 2025 | 6 | 0.060 |
Why?
| Molecular Conformation | 1 | 2005 | 70 | 0.060 |
Why?
| Genes, p53 | 1 | 2005 | 52 | 0.060 |
Why?
| Genes, Tumor Suppressor | 1 | 2005 | 74 | 0.060 |
Why?
| Alternative Splicing | 1 | 2005 | 62 | 0.060 |
Why?
| Ovary | 1 | 2005 | 107 | 0.060 |
Why?
| Leukocytes, Mononuclear | 1 | 2025 | 123 | 0.060 |
Why?
| Cations, Divalent | 1 | 2004 | 6 | 0.060 |
Why?
| Phosphopyruvate Hydratase | 1 | 2024 | 10 | 0.060 |
Why?
| Vitreous Body | 1 | 2024 | 19 | 0.060 |
Why?
| Iron-Sulfur Proteins | 1 | 2004 | 9 | 0.060 |
Why?
| Paracentesis | 1 | 2024 | 13 | 0.060 |
Why?
| Eye Proteins | 1 | 2024 | 16 | 0.060 |
Why?
| Transfection | 1 | 2005 | 357 | 0.060 |
Why?
| Organizational Objectives | 2 | 2014 | 35 | 0.060 |
Why?
| Metals | 1 | 2004 | 36 | 0.060 |
Why?
| Survival Analysis | 2 | 2016 | 673 | 0.060 |
Why?
| Sequence Alignment | 1 | 2004 | 125 | 0.060 |
Why?
| Cloning, Molecular | 1 | 2004 | 190 | 0.060 |
Why?
| Age Distribution | 2 | 2014 | 174 | 0.050 |
Why?
| Receptors, Urokinase Plasminogen Activator | 1 | 2003 | 2 | 0.050 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2003 | 7 | 0.050 |
Why?
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2003 | 13 | 0.050 |
Why?
| Glutathione S-Transferase pi | 1 | 2003 | 25 | 0.050 |
Why?
| Cell Survival | 2 | 2021 | 612 | 0.050 |
Why?
| Deoxyguanosine | 1 | 2003 | 27 | 0.050 |
Why?
| Blotting, Northern | 1 | 2003 | 106 | 0.050 |
Why?
| Clone Cells | 1 | 2003 | 77 | 0.050 |
Why?
| Vitrectomy | 1 | 2024 | 61 | 0.050 |
Why?
| Transcription Factor AP-1 | 1 | 2003 | 61 | 0.050 |
Why?
| Molecular Docking Simulation | 1 | 2023 | 88 | 0.050 |
Why?
| Pilot Projects | 2 | 2020 | 721 | 0.050 |
Why?
| Glutathione Transferase | 1 | 2003 | 174 | 0.050 |
Why?
| Receptors, Cell Surface | 1 | 2003 | 118 | 0.050 |
Why?
| Kinetics | 1 | 2004 | 626 | 0.050 |
Why?
| Mice, Inbred C57BL | 2 | 2019 | 1884 | 0.050 |
Why?
| Herbal Medicine | 1 | 2002 | 3 | 0.050 |
Why?
| Dactinomycin | 1 | 2002 | 23 | 0.050 |
Why?
| Nucleic Acid Synthesis Inhibitors | 1 | 2002 | 15 | 0.050 |
Why?
| RNA Stability | 1 | 2002 | 25 | 0.050 |
Why?
| Inheritance Patterns | 1 | 2021 | 22 | 0.050 |
Why?
| Smad Proteins | 1 | 2021 | 12 | 0.050 |
Why?
| Incineration | 1 | 2021 | 5 | 0.050 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2021 | 29 | 0.050 |
Why?
| Mitochondria | 1 | 2005 | 430 | 0.050 |
Why?
| Amino Acids | 1 | 2023 | 377 | 0.050 |
Why?
| Testis | 1 | 2021 | 72 | 0.050 |
Why?
| Prognosis | 2 | 2017 | 2099 | 0.050 |
Why?
| Drug Screening Assays, Antitumor | 1 | 2021 | 136 | 0.040 |
Why?
| Staining and Labeling | 2 | 2016 | 97 | 0.040 |
Why?
| Maternal Nutritional Physiological Phenomena | 1 | 2021 | 58 | 0.040 |
Why?
| Drug Evaluation, Preclinical | 1 | 2021 | 146 | 0.040 |
Why?
| Phytoestrogens | 2 | 2014 | 23 | 0.040 |
Why?
| Small Molecule Libraries | 1 | 2021 | 67 | 0.040 |
Why?
| Loneliness | 1 | 2020 | 14 | 0.040 |
Why?
| Hypesthesia | 1 | 2020 | 16 | 0.040 |
Why?
| Chemistry Techniques, Synthetic | 1 | 2020 | 21 | 0.040 |
Why?
| Memory Disorders | 1 | 2020 | 49 | 0.040 |
Why?
| Alcohol Oxidoreductases | 1 | 2020 | 13 | 0.040 |
Why?
| Lymphangioleiomyomatosis | 1 | 2020 | 4 | 0.040 |
Why?
| Wound Healing | 1 | 2022 | 219 | 0.040 |
Why?
| Child, Preschool | 3 | 2016 | 4076 | 0.040 |
Why?
| Fear | 1 | 2020 | 82 | 0.040 |
Why?
| Hep G2 Cells | 1 | 2019 | 39 | 0.040 |
Why?
| Adaptation, Psychological | 1 | 2020 | 230 | 0.040 |
Why?
| Oxidative Stress | 1 | 2003 | 807 | 0.040 |
Why?
| Acetylcysteine | 1 | 2019 | 102 | 0.040 |
Why?
| Rats, Wistar | 1 | 2019 | 193 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2023 | 1678 | 0.040 |
Why?
| Adolescent | 3 | 2016 | 6739 | 0.040 |
Why?
| Linear Models | 1 | 2019 | 287 | 0.040 |
Why?
| Fibrosis | 1 | 2019 | 196 | 0.040 |
Why?
| Biopsy | 1 | 2020 | 605 | 0.040 |
Why?
| Aging | 1 | 2003 | 701 | 0.040 |
Why?
| Diet, Atherogenic | 1 | 2017 | 10 | 0.040 |
Why?
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 40 | 0.030 |
Why?
| Injections, Intraperitoneal | 1 | 2017 | 57 | 0.030 |
Why?
| Calcium Phosphates | 1 | 2016 | 5 | 0.030 |
Why?
| Gene Regulatory Networks | 1 | 2017 | 111 | 0.030 |
Why?
| Genetic Loci | 1 | 2016 | 49 | 0.030 |
Why?
| Polymers | 1 | 2016 | 49 | 0.030 |
Why?
| Child | 3 | 2016 | 7248 | 0.030 |
Why?
| Public Health Surveillance | 1 | 2016 | 18 | 0.030 |
Why?
| Acetaminophen | 1 | 2019 | 279 | 0.030 |
Why?
| Child Mortality | 1 | 2016 | 12 | 0.030 |
Why?
| Exercise | 1 | 2020 | 547 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 182 | 0.030 |
Why?
| Age Factors | 2 | 2014 | 1132 | 0.030 |
Why?
| Lung | 1 | 2020 | 509 | 0.030 |
Why?
| Ethinyl Estradiol | 1 | 2015 | 8 | 0.030 |
Why?
| Bayes Theorem | 1 | 2016 | 121 | 0.030 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2015 | 50 | 0.030 |
Why?
| Environment | 1 | 2016 | 89 | 0.030 |
Why?
| Models, Theoretical | 1 | 2016 | 185 | 0.030 |
Why?
| Health Status Disparities | 1 | 2018 | 215 | 0.030 |
Why?
| Sp Transcription Factors | 1 | 2014 | 6 | 0.030 |
Why?
| Pentacyclic Triterpenes | 1 | 2014 | 8 | 0.030 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2015 | 66 | 0.030 |
Why?
| Cluster Analysis | 1 | 2015 | 233 | 0.030 |
Why?
| Triterpenes | 1 | 2014 | 11 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2014 | 87 | 0.030 |
Why?
| Lysine | 1 | 2015 | 89 | 0.030 |
Why?
| Transplantation, Heterologous | 1 | 2014 | 79 | 0.030 |
Why?
| Schools | 1 | 2016 | 172 | 0.030 |
Why?
| Gestational Age | 1 | 2016 | 417 | 0.030 |
Why?
| Case-Control Studies | 1 | 2018 | 1201 | 0.030 |
Why?
| Epidemics | 1 | 2014 | 25 | 0.030 |
Why?
| Immunity, Innate | 1 | 2015 | 117 | 0.030 |
Why?
| Sex Distribution | 1 | 2014 | 137 | 0.030 |
Why?
| Mice, Nude | 1 | 2014 | 265 | 0.030 |
Why?
| Stem Cells | 1 | 2015 | 177 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 185 | 0.030 |
Why?
| Genome | 1 | 2014 | 62 | 0.030 |
Why?
| Epithelial Cells | 1 | 2015 | 215 | 0.030 |
Why?
| Blotting, Western | 1 | 2014 | 590 | 0.030 |
Why?
| Acetylation | 1 | 2013 | 95 | 0.030 |
Why?
| Cause of Death | 1 | 2014 | 160 | 0.030 |
Why?
| Life Style | 1 | 2014 | 145 | 0.030 |
Why?
| Models, Statistical | 1 | 2014 | 230 | 0.030 |
Why?
| Pregnancy Complications, Infectious | 1 | 2014 | 81 | 0.030 |
Why?
| Saliva | 1 | 2012 | 56 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2016 | 1229 | 0.020 |
Why?
| Cell Line | 1 | 2015 | 1030 | 0.020 |
Why?
| Infant | 2 | 2012 | 3733 | 0.020 |
Why?
| Prevalence | 1 | 2016 | 1006 | 0.020 |
Why?
| Socioeconomic Factors | 1 | 2014 | 610 | 0.020 |
Why?
| Nerve Tissue Proteins | 1 | 2013 | 187 | 0.020 |
Why?
| Neoplasm Recurrence, Local | 1 | 2016 | 649 | 0.020 |
Why?
| Carrier Proteins | 1 | 2013 | 313 | 0.020 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2018 | 560 | 0.020 |
Why?
| Incidence | 1 | 2014 | 1062 | 0.020 |
Why?
| In Situ Hybridization | 1 | 2010 | 64 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 74 | 0.020 |
Why?
| Hemochromatosis | 1 | 2009 | 3 | 0.020 |
Why?
| Antigens, Surface | 1 | 2009 | 47 | 0.020 |
Why?
| Ohio | 1 | 2009 | 45 | 0.020 |
Why?
| Manganese | 1 | 2009 | 23 | 0.020 |
Why?
| Statistics as Topic | 1 | 2009 | 87 | 0.020 |
Why?
| Obesity | 1 | 2018 | 1162 | 0.020 |
Why?
| Dihydrotestosterone | 1 | 2007 | 14 | 0.020 |
Why?
| Time Factors | 1 | 2014 | 2968 | 0.020 |
Why?
| United States | 1 | 2018 | 5192 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2009 | 505 | 0.020 |
Why?
| Anticarcinogenic Agents | 1 | 2006 | 32 | 0.020 |
Why?
| Caspase 3 | 1 | 2006 | 95 | 0.020 |
Why?
| Down-Regulation | 1 | 2007 | 346 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2006 | 213 | 0.020 |
Why?
| TATA Box | 1 | 2004 | 8 | 0.010 |
Why?
| Dinucleoside Phosphates | 1 | 2004 | 7 | 0.010 |
Why?
| DNA Primers | 1 | 2004 | 208 | 0.010 |
Why?
| Orchiectomy | 1 | 2003 | 38 | 0.010 |
Why?
| Rats, Inbred Strains | 1 | 2003 | 187 | 0.010 |
Why?
| Oxidoreductases | 1 | 2003 | 59 | 0.010 |
Why?
| Precancerous Conditions | 1 | 2004 | 85 | 0.010 |
Why?
| Retrospective Studies | 1 | 2016 | 6607 | 0.010 |
Why?
| Aldehydes | 1 | 2003 | 81 | 0.010 |
Why?
| Peptide Elongation Factor 1 | 1 | 2003 | 2 | 0.010 |
Why?
| Clusterin | 1 | 2003 | 8 | 0.010 |
Why?
| Neoplasm Metastasis | 1 | 2004 | 243 | 0.010 |
Why?
| Amino Acyl-tRNA Synthetases | 1 | 2003 | 6 | 0.010 |
Why?
| Postoperative Period | 1 | 2003 | 170 | 0.010 |
Why?
| Cytoskeleton | 1 | 2003 | 39 | 0.010 |
Why?
| Regeneration | 1 | 2003 | 79 | 0.010 |
Why?
| Molecular Chaperones | 1 | 2003 | 66 | 0.010 |
Why?
| Alkaline Phosphatase | 1 | 2003 | 94 | 0.010 |
Why?
| Glycoproteins | 1 | 2003 | 122 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2009 | 3392 | 0.010 |
Why?
| Membrane Glycoproteins | 1 | 2003 | 244 | 0.010 |
Why?
| Neoplasm Staging | 1 | 2004 | 772 | 0.010 |
Why?
|
|
Leung's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|